These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6280564)

  • 21. Intercostal muscle acetylcholine receptors in longstanding ocular myasthenia.
    Lecky BR; Morgan-Hughes JA; Landon DN; Murray NM
    Lancet; 1980 Dec; 2(8207):1311-2. PubMed ID: 6108490
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of human myasthenia gravis: electrophysiological and ultrastructural evidence compatible with antibody attachment to acetylcholine receptor complex.
    Rash JE; Albuquerque EX; Hudson CS; Mayer RF; Satterfield JR
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4584-8. PubMed ID: 1070009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture.
    Bevan S; Kullberg RW; Heinemann SF
    Nature; 1977 May; 267(5608):263-5. PubMed ID: 865619
    [No Abstract]   [Full Text] [Related]  

  • 24. Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.
    Engel AG; Nagel A; Walls TJ; Harper CM; Waisburg HA
    Muscle Nerve; 1993 Dec; 16(12):1284-92. PubMed ID: 8232383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
    Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-acetylcholine receptor antibodies induced in mice by syngeneic receptor without adjuvants.
    Scadding GK; Calder L; Vincent A; Prior C; Wray D; Newsom-Davis J
    Immunology; 1986 May; 58(1):151-5. PubMed ID: 3486818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in related neuromuscular diseases (author's transl)].
    Tsujihata M; Hazama R; Ishii N; Ide Y; Takamori M
    Rinsho Shinkeigaku; 1979 Nov; 19(11):751-9. PubMed ID: 535300
    [No Abstract]   [Full Text] [Related]  

  • 29. Properties of end-plate channels in rats immunized against acetylcholine receptors.
    Alemà S; Cull-Candy SG; Miledi R; Trautmann A
    J Physiol; 1981 Feb; 311():251-66. PubMed ID: 6267252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcholine receptors and end-plate electrophysiology in myasthenia gravis.
    Ito Y; Miledi R; Vincent A; Newsom-Davis J
    Brain; 1978 Jun; 101(2):345-68. PubMed ID: 667602
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pseudoparalytic myasthenia gravis. Diagnostic and therapeutic aspects in 60 separate cases].
    Mumenthaler M; Lütschg J
    Schweiz Arch Neurol Neurochir Psychiatr; 1976; 118(1):23-56. PubMed ID: 981976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. End-plate currents and acetylcholine noise at normal and myasthenic human end-plates.
    Cull-Candy SG; Miledi R; Trautmann A
    J Physiol; 1979 Feb; 287():247-65. PubMed ID: 430403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of drugs and antibodies on the post-synaptic membrane of the neuromuscular junction.
    Peper K; Sterz R; Bradley RJ
    Ann N Y Acad Sci; 1981; 377():519-43. PubMed ID: 6978665
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The time course of miniature endplate currents and its modification by receptor blockade and ethanol.
    Linder TM; Pennefather P; Quastel DM
    J Gen Physiol; 1984 Mar; 83(3):435-68. PubMed ID: 6325590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myasthenia gravis and acetylcholine].
    Fujioka T
    Brain Nerve; 2014 May; 66(5):517-25. PubMed ID: 24807368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of acetylcholine receptor by antibody against the receptor.
    Heinemann S; Bevan S; Kullberg R; Lindstrom J; Rice J
    Proc Natl Acad Sci U S A; 1977 Jul; 74(7):3090-4. PubMed ID: 268657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human myasthenia: a metabolic disease of the motor neuron].
    Desmedt JE
    Arch Ital Biol; 1973 Dec; 111(3-4):336-51. PubMed ID: 18847035
    [No Abstract]   [Full Text] [Related]  

  • 39. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Observation on the changes in the frequency of end-plate potentials evoked by sera with different antibodies from patients with myasthenia gravis in nerve-muscle preparation of rats].
    Lu C
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Feb; 25(1):44-6, 63. PubMed ID: 1317284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.